NUVEEN ASSET MANAGEMENT, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
NUVEEN ASSET MANAGEMENT, LLC portfolio value:
$3.32B
portfolio value
NUVEEN ASSET MANAGEMENT, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +5486.11% | 16.29M shares | 3.27B | $200.16 | 16.59M |
Q2 2022 | share | Decrease | -17.95% | -64.99K shares | -15.48M | $145.85 | 297.04K |
Q1 2022 | share | Decrease | -38.69% | -228.50K shares | -41.33M | $163.29 | 362.03K |
Q4 2021 | share | Decrease | -23.01% | -176.48K shares | -44.67M | $171.03 | 590.54K |
Q3 2021 | put | Decrease | -100.00% | -31K shares | -5K | $188.81 | 0 |
Q3 2021 | share | Increase | +17.46% | 114.02K shares | 34.12M | $188.81 | 767.03K |
Q2 2021 | put | Increase | 0.00% | 31K shares | 5K | $169.52 | 31K |
Q2 2021 | share | Increase | +9.57% | 57.00K shares | 26.54M | $169.52 | 653.00K |
Q1 2021 | share | Decrease | -0.45% | -2.7K shares | 6.33M | $141.19 | 596K |
Q4 2020 | share | Increase | +40.09% | 171.32K shares | 15.58M | $129.97 | 598.7K |
Q3 2020 | share | Decrease | -5.78% | -26.19K shares | -4.95M | $145.6 | 427.37K |
Q2 2020 | share | Decrease | -11.91% | -61.3K shares | 11.13M | $148.11 | 453.56K |
Q1 2020 | share | Increase | +27.58% | 111.31K shares | 9.56M | $108.85 | 514.86K |
Q4 2019 | share | Decrease | -3.04% | -12.65K shares | 13.00M | $115.17 | 403.55K |
Q3 2019 | share | Increase | +6.54% | 25.55K shares | 5.12M | $80.42 | 416.21K |
Q2 2019 | share | Increase | 0.00% | 390.66K shares | 28.34M | $72.56 | 390.66K |